These results suggest that, besides 25(OH)D levels, the VDR-mediated response to active vitamin D or the VDBP-regulated exposure to active vitamin D could also be associated with the risk and progression of cancer, and could be considered additional variables in determining the vitamin D-related cancer risk and progression of cancer. The gene discussed is GC; the disease is cancer.